Page last updated: 2024-09-03
ud cg 212 cl and h 89
ud cg 212 cl has been researched along with h 89 in 1 studies
Compound Research Comparison
Studies (ud cg 212 cl) | Trials (ud cg 212 cl) | Recent Studies (post-2010) (ud cg 212 cl) | Studies (h 89) | Trials (h 89) | Recent Studies (post-2010) (h 89) |
---|---|---|---|---|---|
28 | 2 | 0 | 1,619 | 0 | 409 |
Protein Interaction Comparison
Protein | Taxonomy | ud cg 212 cl (IC50) | h 89 (IC50) |
---|---|---|---|
Rho-associated protein kinase 2 | Homo sapiens (human) | 1.9504 | |
Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.12 | |
cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.073 | |
cAMP-dependent protein kinase catalytic subunit alpha | Mus musculus (house mouse) | 0.381 | |
cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | 0.6365 | |
cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | 0.6365 | |
cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | 0.6365 | |
Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | 0.08 | |
RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 1.9886 | |
RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.5417 | |
Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | 0.27 | |
RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.3207 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, CH; Kubo, M; Minami, K; Nakaya, Y | 1 |
Other Studies
1 other study(ies) available for ud cg 212 cl and h 89
Article | Year |
---|---|
Effects of pimobendan and its active metabolite, UD-CG 212 Cl, on Ca2+-activated K+ channels in vascular smooth-muscle cells.
Topics: Animals; Calcium; Cardiotonic Agents; Coronary Vessels; Drug Interactions; Enzyme Inhibitors; Heart; Isoquinolines; Muscle, Smooth, Vascular; Potassium Channels; Pyridazines; Sulfonamides; Swine; Vasodilation | 1997 |